Amgen Inc (NAS:AMGN)
$ 311.63 3.18 (1.03%) Market Cap: 167.17 Bil Enterprise Value: 219.78 Bil PE Ratio: 44.52 PB Ratio: 33.29 GF Score: 88/100

Q2 2020 Amgen Inc Earnings Call Transcript

Jul 28, 2020 / 09:00PM GMT
Release Date Price: $255.27 (+0.64%)
Operator

My name is Erica, and I will be your conference facilitator today for Amgen's Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may begin.

Arvind Sood
Amgen Inc. - VP of IR

Thank you, Erica. Good afternoon, everybody, and welcome to our Q2 call. This call is going to feel a bit different than our previous earnings calls because we are making some changes. As a matter of fact, in response to feedback from many of you that our prepared comments are too long, we are going to limit our prepared comments to around 20 minutes. We'll also limit the duration of the call to 1 hour. Now that doesn't mean that we are scaling back on disclosure. You'll notice our press release has been enriched to provide explanations that were previously included in our prepared comments. We think this approach will free up time for Q&A. But to make sure that everyone has an opportunity to ask a question, we are still going to request that you stick to asking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot